CIPLA
Quarterly Results Analysis [Mar2025]
CIPLA Quarterly Results
Consolidated | Mar2025 UnAudited |
Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹6,730 Cr | ₹7,073 Cr | ₹7,051 Cr | ₹6,694 Cr | ₹6,163 Cr | ₹6,604 Cr | ₹6,678 Cr | ₹6,329 Cr |
Expenses | ₹5,192 Cr | ₹5,084 Cr | ₹5,165 Cr | ₹4,978 Cr | ₹4,847 Cr | ₹4,856 Cr | ₹4,944 Cr | ₹4,835 Cr |
Operating Income | ₹1,538 Cr | ₹1,989 Cr | ₹1,886 Cr | ₹1,716 Cr | ₹1,316 Cr | ₹1,748 Cr | ₹1,734 Cr | ₹1,494 Cr |
Other Income | ₹289 Cr | ₹222 Cr | ₹191 Cr | ₹160 Cr | ₹249 Cr | ₹185 Cr | ₹176 Cr | ₹136 Cr |
Interest | ₹14 Cr | ₹15 Cr | ₹15 Cr | ₹18 Cr | ₹18 Cr | ₹30 Cr | ₹26 Cr | ₹16 Cr |
Depreciation | ₹309 Cr | ₹280 Cr | ₹272 Cr | ₹247 Cr | ₹288 Cr | ₹233 Cr | ₹290 Cr | ₹239 Cr |
Profit Before Tax | ₹1,504 Cr | ₹1,916 Cr | ₹1,789 Cr | ₹1,611 Cr | ₹1,259 Cr | ₹1,474 Cr | ₹1,594 Cr | ₹1,375 Cr |
Profit After Tax | ₹1,225 Cr | ₹1,584 Cr | ₹1,306 Cr | ₹1,176 Cr | ₹934 Cr | ₹1,069 Cr | ₹1,156 Cr | ₹997 Cr |
EPS | ₹15.13 | ₹19.45 | ₹16.13 | ₹14.58 | ₹11.63 | ₹13.08 | ₹14.01 | ₹12.33 |
Industry Peers & Returns | 1W | 1M | 1Y |
CIPLA | 2.6% | -0.1% | 0.6% |
SUN PHARMACEUTICAL INDUSTRIES | 1.4% | 0.1% | 13.9% |
DIVIS LABORATORIES | 0.8% | 12.3% | 47.2% |
TORRENT PHARMACEUTICALS | 2.7% | -0.6% | 14.4% |
DR REDDYS LABORATORIES | 7.8% | 12.9% | 13.3% |
MANKIND PHARMA | 1.3% | -4.8% | 9.3% |
ZYDUS LIFESCIENCES | 5.4% | 11% | -7.3% |
LUPIN | 3.3% | -1.7% | 22.3% |
AUROBINDO PHARMA | 2.8% | -2.9% | -8.3% |
CIPLA Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | -4.85 % |
Y-o-Y | 9.19 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Mar2025 | ₹6,730 Cr | -4.85 | |
Dec2024 | ₹7,073 Cr | 0.31 | |
Sep2024 | ₹7,051 Cr | 5.33 | |
Jun2024 | ₹6,694 Cr | 8.61 | |
Mar2024 | ₹6,163 Cr | -6.67 | |
Dec2023 | ₹6,604 Cr | -1.11 | |
Sep2023 | ₹6,678 Cr | 5.52 | |
Jun2023 | ₹6,329 Cr | - |
CIPLA Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | -22.69 % |
Y-o-Y | 16.85 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Mar2025 | ₹1,538 Cr | -22.69 | |
Dec2024 | ₹1,989 Cr | 5.48 | |
Sep2024 | ₹1,886 Cr | 9.90 | |
Jun2024 | ₹1,716 Cr | 30.39 | |
Mar2024 | ₹1,316 Cr | -24.70 | |
Dec2023 | ₹1,748 Cr | 0.79 | |
Sep2023 | ₹1,734 Cr | 16.05 | |
Jun2023 | ₹1,494 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | -18.74 % |
Y-o-Y | 7.03 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Mar2025 | 22.85% | -18.74 | |
Dec2024 | 28.12% | 5.16 | |
Sep2024 | 26.74% | 4.33 | |
Jun2024 | 25.63% | 20.05 | |
Mar2024 | 21.35% | -19.31 | |
Dec2023 | 26.46% | 1.93 | |
Sep2023 | 25.96% | 10.00 | |
Jun2023 | 23.6% | - |
CIPLA Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | -22.65 % |
Y-o-Y | 31.10 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Mar2025 | ₹1,225 Cr | -22.65 | |
Dec2024 | ₹1,584 Cr | 21.26 | |
Sep2024 | ₹1,306 Cr | 11.03 | |
Jun2024 | ₹1,176 Cr | 25.89 | |
Mar2024 | ₹934 Cr | -12.55 | |
Dec2023 | ₹1,069 Cr | -7.55 | |
Sep2023 | ₹1,156 Cr | 15.98 | |
Jun2023 | ₹997 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | -18.71 % |
Y-o-Y | 20.05 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2025 | 18.2 % | -18.71 | |
Dec2024 | 22.39 % | 20.90 | |
Sep2024 | 18.52 % | 5.41 | |
Jun2024 | 17.57 % | 15.90 | |
Mar2024 | 15.16 % | -6.30 | |
Dec2023 | 16.18 % | -6.53 | |
Sep2023 | 17.31 % | 9.90 | |
Jun2023 | 15.75 % | - |
CIPLA Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | -22.21 % |
Y-o-Y | 30.09 % |
Quarters | EPS | % Change | |
---|---|---|---|
Mar2025 | ₹15.13 | -22.21 | |
Dec2024 | ₹19.45 | 20.58 | |
Sep2024 | ₹16.13 | 10.63 | |
Jun2024 | ₹14.58 | 25.37 | |
Mar2024 | ₹11.63 | -11.09 | |
Dec2023 | ₹13.08 | -6.64 | |
Sep2023 | ₹14.01 | 13.63 | |
Jun2023 | ₹12.33 | - |
You may also like the below Video Courses